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Can Doppler or contrast-enhanced ultrasound analy-
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OBJECTIVES: Despite evidence suggesting that Doppler ultrasonography can help to differentiate between
benign and malignant breast lesions, it is rarely applied in clinical practice. The aim of this study was to
determine whether certain vascular features of breast masses observed by duplex Doppler and color Doppler
ultrasonography (before and/or after microbubble contrast injection) add information to the gray-scale analysis
and support the Breast Imaging-Reporting and Data System (BI-RADS) classification.
METHODS: Seventy solid lesions were prospectively evaluated with gray-scale ultrasonography, color Doppler
ultrasonography, and contrast-enhanced ultrasonography. The morphological analysis and lesion vascularity
were correlated with the histological results.
RESULTS: Percutaneous core biopsies revealed that 25/70 (17.5%) lesions were malignant, while 45 were
benign. Hypervascular lesions with tortuous and central vessels, a resistive index (RI)$0.73 before contrast
injection, and an RI$0.75 after contrast injection were significantly predictive of malignancy (p,0.001).
CONCLUSION: The combination of gray-scale ultrasonography data with unenhanced or enhanced duplex
Doppler and color Doppler US data can provide diagnostically useful information. These techniques can be
easily implemented because Doppler devices are already present in most health centers.
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& INTRODUCTION
Although breast sonograms are not generally used in
diagnostic screening for breast cancer, they are a standard
procedure for examining dense breasts in women at
elevated risk for breast cancer (1,2) and are used to
differentiate between benign and malignant masses (3). In
2003, the American College of Radiology published the
Breast Imaging-Reporting and Data System (BI-RADSH)
lexicon for ultrasonography (US), in which they provided a
unified language and a standardized classification system
(4). The descriptors used are mainly related to lesion
morphology. There are also descriptors related to lesion
vascularity; however, these descriptors are simplistic and
add little information (i.e., the presence or absence; and
localization within the lesion, adjacent to the lesion, or in
surrounding tissue).
Malignant tumors commonly produce pro-angiogenic
factors that stimulate the growth of new vessels. New
vessels differ from native ones in that the new vessels are
irregular, tortuous, and of variable caliber, and they form
reticular networks with arteriovenous shunts and dichot-
omous branching (5). Previous reports have indicated that
duplex Doppler US (color Doppler associated with pulsed/
spectrum analysis) can be used to demonstrate these typical
features of neovascularization in the vicinity of malignant
lesions (6-8). Contrast-enhanced US (CEUS) is an important
diagnostic tool because CEUS can reveal additional infor-
mation about lesion vascularity. Furthermore, CEUS does
not expose patients to ionizing radiation (such as mammo-
graphy) and is not nephrotoxic, such as magnetic resonance
imaging (MRI) contrast agents (9).
Contrast breast US is a relatively new modality, and its
applications are still being evaluated. Preliminary studies
involving ‘‘first-generation’’ contrast media and color Doppler
have yielded encouraging results (10-12). Subsequent studies
performed with ‘‘second-generation’’ contrast media (with
more stable and durable microbubbles) and harmonic pulse
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inversion have enabled qualitative and quantitative analyses of
contrast-enhanced images, which provide further information
about vascular morphologic patterns and distribution features
(13-15). Despite these advances, there is still no consensus
regarding the use of contrast US for evaluating breast masses.
This study is the first in Brazil to address the clinical
applicability of unenhanced and enhanced duplex Doppler
in evaluating breast lesions. The aim of the present work
was to assess how well gray-scale morphological analysis
and lesion vascularity data correlate with the histopatholo-
gical findings, the gold standard in lesion diagnosis.
& MATERIALS AND METHODS
Patients
This study was conducted in the US service department
at Hospital das Clı´nicas da Faculdade de Medicina da
Universidade de Sa˜o Paulo in Sa˜o Paulo, Brazil between
March 2007 and January 2008. Breast Diagnostics Center
patients who had previously been diagnosed with breast
lesions (category 4 or 5) and had a clinically or radiologi-
cally indicated percutaneous breast biopsy were recruited.
The initial group of samples included 93 breast masses
from 73 patients. The patients with atypical pathology
results and who did not return for excisional surgery (n = 9)
were excluded because an analysis of only a few fragments
may not be representative of the entire lesion. The final
analysis included 70 solid breast masses in 64 women who
were subjected to percutaneous biopsy via core biopsy.
These 64 patients ranged in age from 18 to 78 years (median,
49.12 years). All patients provided full informed consent
to participate in the study, which was approved by our
institutional review board (the Ethics Committee of Hospital
das Clı´nicas da Faculdade de Medicina da Universidade de
Sa˜o Paulo) on November 23, 2006 (protocol 1021/06).
Study design
All exams were performed by two radiologists, each with
more than 10 years of experience with breast US (D.S. and
M.C.C.). The US examinations were performed with a
TOSHIBA-APLIO XG machine (2007 model year, Tokyo,
Japan) equipped with a 5– to 14-MHz linear transducer.
Static and dynamic images obtained during the examina-
tions were archived electronically.
Pre-contrast examination
Although the masses had already been classified as BI-
RADS 4 or 5 at the Diagnosis Center of Breast Diseases in
the Hospital das Clı´nicas, all masses were reevaluated and
reclassified, disregarding the prior clinical findings. The
lesions presenting typically benign features were categor-
ized as probably benign (BI-RADS 3), even if they were
palpable (30 lesions); lesions with 1 suspicious malignancy
criterion (or more) were classified as BI-RADS 4 or 5.
Following a gray-scale evaluation, each patient was
assessed with color Doppler US (CDUS). The CDUS settings
were optimized to detect low-velocity or low-volume blood
flow. The color box was adjusted to include the lesion and a
margin of normal breast tissue. The color gain was increased
until background noise appeared and then reduced until the
noise was suppressed and small vessels could be detected.
The examinations were performed with minimal probe
pressure to prevent vessel collapse.
Table 1 - Methods and descriptors used to classify lesions.
Method Classification Descriptors
PRECONTRAST ANALYSIS
Gray Scale BI-RADS BI-RADS Descriptors BI-RADS 3
Not BI-RADS 3
CDUS Qualitative Number of Arteries Avascular (None Detected)
Hypovascular (1-2 Arteries)
Hypervascular (3 or More Arteries)
Distribution of Arteries Regular
Irregular
Morphology of Arteries Peripheral
Central
Penetrating Artery
Quantitative Spectral Analysis RI
POS CONTRAST ANALYSIS
PIH + Low MI Kinectic Analysis Wash-In
Wash-Out
Amount of Enhancement Absent
Minimal
Moderate
Intense
E-CDUS Qualitative Number Avascular
Hypovascular
Hypervascular
Distribution Regular
Irregular
Morphology Peripheral
Central
Penetrating Artery
Quantitative Spectral Analysis RI
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The lesions were evaluated qualitatively according the
criteria described by Moon et al. (12), which are summar-
ized in Table 1. We also recorded whether penetrating
vessels, which are highly indicative of malignancy, were
present, as described by Raza and Baum (7). The lesions
were classified as probably benign (avascular or hypovas-
cular lesions with regular and peripheral vessels, Figures 1
and 2), probably malignant (hypervascular lesions with
irregular vessels and a central distribution, with or without
an observable penetrating artery, Figure 3), or suspicious
(any other pattern variant, Figure 4).
We also performed a quantitative study using spectral
Doppler US. The resistive index (RI) was measured for all
vessels around hypovascular lesions. For the hypervascular
lesions, measurements were taken for three or four different
vessels, and the data from the largest vessel were recorded.
This criterion was used in isolation and was not considered
in the final assessments.
Post-contrast examination
Two contrast agents were used. A commercially available
agent was used with 34 patients (DefinityH, Bristol-Myers
Squibb, City, MA, USA), and another agent manufactured in
our hospital was used with 30 patients (perfluorocarbon-
exposed sonicated albumin [PESDA]). The in-house PESDA
was prepared as described by Porter at al. (16). None of the
patients experienced an adverse reaction.
After catheterizing a peripheral vein, a bolus of contrast
medium (3 mL of PESDA or 0.01 mL/kg of DefinityH) was
injected into the antecubital vessel, followed by 10 mL of saline
solution. Before injecting the contrast medium, the display
parameters were changed for a contrast exam (pulse-inversion
harmonica and mechanical index #0.17). As soon as the
contrast agent bolus was injected, the time button was activated.
The wash-in time (the delay until reaching the maximum
intensity peak), wash-out time (the delay until the max-
imum intensity inside the mass declined to the baseline),
and the amount of enhancement after the contrast agent
injection were recorded. Enhancement was classified into
four categories: absent (no change in mass echogenicity),
minimal (small or equivocal enhancement), moderate
(partial enhancement), or intense (maximal/robust enhance-
ment). This classification was performed in a subjective
manner based on the observed variation in enhancement
intensity in the lesion after the contrast agent was injected
because an objective, validated quantitative method for this
evaluation type was not available (Table 1).
Figure 1 - A fibroadenoma found in the left breast of a 47-year-
old woman. A) Gray-scale image showing an irregular, micro-
lobulated mass (BI-RADS 4). B) Color Doppler image showing a
peripheral regular artery. C) After contrast injection, we
observed moderate peripheral enhancement. D) An enhanced
color Doppler image showing the same aspect as that shown for
the non-enhanced color Doppler image in B. No additional
arteries were observed. Power Doppler imaging was used only to
produce clearer images for illustration purposes.
Figure 2 - An invasive ductal carcinoma recurrence in the left
breast of a 63-year-old woman. A) A gray-scale image showing
an irregular, spiculated mass with an echogenic halo, architec-
tural distortion, acoustic shadowing, and straightening of
Cooper’s ligament (BI-RADS 5). B) A color Doppler image
showing an avascular lesion. C) After contrast injection, there
was minimal enhancement. D) An enhanced color Doppler image
showing an avascular lesion.
Figure 3 - An invasive ductal carcinoma in the right breast of a
71-year-old woman. A) A gray-scale image showing an irregular,
microlobulated mass with an echogenic halo and acoustic
shadowing (BI-RADS not 3). B) A color Doppler image showing
a hypervascular lesion with central and irregular arteries. C) After
contrast injection, there was intense enhancement. D) An
enhanced color Doppler image showed the same pattern as
the unenhanced CDUS. Power Doppler imaging was used only to
produce clearer images for illustration purposes.
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After the wash-out period, we re-analyzed the number of
vessels and their characteristics using CDUS after contrast
injection and classified the findings based on the parameters
described above. We also obtained new vessel RI measure-
ments after the contrast media injection (Table 1).
Histopathology
After the US analysis, all patients, including those whose
masses were graded as BI-RADS 3, returned to the
Diagnosis Center of Breast Diseases for a percutaneous
breast biopsy with a 14-gauge automated BARDH gun and
needle (Bard Radiology, Covington, GA). At least six
fragments were removed from each nodule. The fragments
were fixed in paraffin and histologically analyzed. The final
anatomopathological findings were added to the other
findings and subjected to statistical analysis.
Statistical analysis
The statistical analysis was performed using the chi-
squared test or the independent t-test (when the former
could not be applied). In addition to these tests, receiver
operating characteristic (ROC) curves were developed and
logistical regression analyses of the data were performed.
& RESULTS
Pre-contrast examination
A total of 70 breast masses from 64 patients were subjected to
US analysis and subsequent core biopsies for histopathological
correlation. The benign lesions were most commonly diagnosed
as fibroadenomas (28/45), stromal fibrosis (6/45), or ductal
hyperplasia without atypia (3/45). Approximately 100% of the
malignant lesions were diagnosed as invasive ductal carcino-
mas (23/25), except for one anaplastic neoplasia and one
lymphoma. The findings of the final lesion assessments with
gray-scale US, unenhanced CDUS, and enhanced CDUS are
reported in Table 2.
The following BI-RADS descriptors were highly predic-
tive of malignancy (p,0.001): vertical orientation (80%), no
circumscribed margins (64%), Cooper’s ligament changes
(100%), ductal changes (78.9%), and skin retraction or
irregularity (87%), along with the presence of an echogenic
halo (94.4%) or architectural distortion (100%).
Our CDUS analysis revealed that the majority of the
malignant lesions were characterized by central vascularity
(91.6%), with hypervascularity (68%), a penetrating artery
(66.6%), and tortuous vessels (75%). The benign lesions were
predominantly avascular or hypovascular (60%) and
usually had regular vessels (83.3%). Of the vascular benign
masses, only 16.6% had a penetrant artery.
According to the ROC curve, the best RI cut-off value for
unenhanced spectral Doppler US (highest sensitivity and
specificity) was 0.73; at this value, 76% sensitivity and 71%
specificity were achieved. This RI cut-off value allowed
significant discrimination between the benign and malig-
nant lesions (p,0.001). The 25 analyzed malignant lesions
had a mean RI value of 0.82¡0.16 (range, 0.63–1.46), with 13
(80%) of the malignant lesions having an RI value $0.73
(p,0.001). The mean RI values of the 45 analyzed benign
lesions was 0.48¡0.37 (range, 0.46–1.29), with 14 (31.1%) of
the benign lesions having an RI value $0.73 (p,0.001).
Post-contrast examination
After the contrast agent injection, kinetic analyses were
used to reveal the enhancement degree, wash-in time, and
wash-out time, with the aim of determining whether these
parameters provided useful information in classifying the
lesions as benign or malignant. Most of the malignant lesions
presented moderate (14/25) or intense (7/25) enhancement.
No enhancement was observed in one carcinoma and one
lymphoma; and minimal enhancement was observed in two
carcinomas. For the benign lesions, there was no enhance-
ment in eight cases, minimal enhancement in 11 cases,
moderate enhancement in 17 cases, and intense enhancement
in nine cases (including five fibroadenomas).
The mean wash-in time for the malignant lesions was
27¡11.3 s (range, 14–48 s) and 26.4¡10.7 s (range, 14–45 s)
for the benign lesions. The mean wash-out time for the
Figure 4 - Juvenile fibroadenoma in the left breast of an 18-year-
old woman. A) A gray-scale image showing an oval, circum-
scribed mass (BI-RADS 3). B) A color Doppler image showing a
hypervascular lesion with central and regular arteries. C) An
enhanced color Doppler image showed the same pattern as the
unenhanced CDUS. Power Doppler imaging was used only to
produce clearer images for illustration purposes. D) After
contrast injection, there was intense enhancement.
Table 2 - Final breast lesion assessment using gray-scale US, unenhanced CDUS, and enhanced CDUS.
Final diagnosis Gray-Scale US Unenhanced CDUS Enhanced CDUS
B3 Not B3 PB* S** PM*** PB* S** PM***
Benign 30 (100%) 15 (37.5%) 26 (89.6%) 14 (66.7%) 5 (25%) 21 (91.3%) 18 (81.8%) 6 (24%)
Malignant 0 (0%) 25 (62.5%) 3 (10.3%) 7 (33.3%) 15 (75%) 2 (8.7%) 4 (18.2%) 19 (76%)
Total 30 40 29 21 20 23 22 25
Statistical Analysis
Sensitivity 100% 88% 92%
Specificity 66.6% 57.7% 46.6%
PPV 62.5% 53.6% 48%
NPC 100% 89.9% 91%
*PB: probably benign; **S: suspicious; ***PM: probably malignant.
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malignant lesions was 56.9¡32.3 s (range, 19–180 s) and
56.6¡22.9 s (range, 33–106 s) for the benign lesions. The
ROC curve analysis revealed that the wash-in time and
wash-out time parameters did not effectively discriminate
between the benign and malignant lesions.
The results of our qualitative enhanced CDUS analysis,
following the same criteria used for unenhanced CDUS, are
reported in Table 2. The vast majority (24/25, 96.0%) of the
malignant lesions was hypervascular. Of the 24 hypervas-
cular malignant lesions, 22 (91.6%) had a central distribu-
tion, 17 (70.8%) had a penetrating artery, and 20 (83.3%) had
tortuous vessels. Approximately half (22/45; 48%) of the
benign lesions were avascular or hypovascular. Among the
34 benign lesions that had at least one vessel, a peripheral
vascular pattern was observed in 13 (38.2%) lesions, and a
central pattern was observed in 21 (61.7%) lesions. Most of
the benign lesions with at least one vessel (28/34; 82.3%)
had regular vascular morphology.
The best RI cut-off value, according to the ROC curve (highest
sensitivity and specificity) in the post-contrast study, was 0.75.
With this RI value, 72% sensitivity and 67% specificity were
achieved. This value yielded a significant distinction between
the benign and malignant cases (p,0.001). The post-contrast
quantitative analysis showed that the malignant lesions had a
mean RI value of 0.82¡0.16 (range, 0.63–1.46), with 19 of the
malignant lesions (76%) presenting an RI$0.75 (p= 0.001).
Meanwhile, the benign lesions had a mean RI value of
0.48¡0.37 (range, 0.46–1.29), with 17 of the benign lesions
(37.8%) having an RI$0.75 (p= 0.001).
& DISCUSSION
In the present study, BI-RADS classification using gray-
scale US examinations showed high sensitivity for detecting
malignant lesions but lacked in specificity, producing a
large number of false positives. This result pattern corrobo-
rates prior BI-RADS classification studies (2,17). The 15 false
positives obtained in our study group were mostly
fibroadenomas.
Although the BI-RADS lexicon has descriptors concerning
mass vascularity, the descriptors are not, in our view,
distinctively characteristic of benign versus malignant lesions;
nor are they particularly useful for describing, classifying, or
managing breast nodules. However, malignant tumors do
display characteristic features in duplex Doppler images, such
as hypervascularity, vessel penetration, irregular vessels, central
vessel distribution, and branching and disordered vessel
morphology (6-12). In our study, we found that hypervascu-
larity, tortuous arteries, vessel penetration, and a central vessel
distribution pattern were significantly associated with malig-
nancy. Our benignity and malignancy results using duplex
Doppler imaging correlated well with our histopathology
diagnoses, supporting the notion that our qualitative evaluation
criteria were efficacious and valid.
Concerning the quantitative analysis, several studies have
described higher RI values in malignant lesions relative to
benign lesions (because of arteriovenous shunts and the
absence of smooth muscle, resulting in high velocity pulsatile
tumoral flow). However, there are no standard cut-off RI
values to differentiate between malignant and benignant
lesions; previously reported cut-off RI values have ranged
from 0.7 to 1.0 (18-21). In our study, optimal sensitivity and
specificity values were obtained with an RI of 0.73 for
unenhanced CDUS and an RI of 0.75 for enhanced CDUS.
Previous studies have revealed diagnostic pitfalls in
unenhanced and enhanced CDUS. Specifically, hypervascu-
larized benign, inflamed lesions, Phyllodes tumors, and
fibroadenomas may be mistaken for malignancies, whereas
hypovascular carcinomas may be missed and falsely
considered to be benign (7,18-22). Our findings were
consistent with these prior reports.
Our kinetic data (i.e., the wash-in time, wash-out time,
and enhancement intensity after contrast injection) did not
differ significantly between the benign and malignant
lesions, although we did observe that most of the malignant
tumors presented with intense enhancement. It may be that
the kinetic analysis failed to produce an association because
the analysis was performed subjectively because of the
absence of objective tools at the time of the study. However,
many authors have described the usefulness of microbubble
enhancement for US evaluation of breast masses, and
the diagnostic accuracy has been reportedly improved by
contrast enhancement (10-12).
More recent studies have shown that not only the analysis of
kinetic curves (similar to MRI) (13) but also the distribution
pattern of contrast within the mass may suggest malignancy
(e.g., heterogeneous or peripheral rim-like hyperenhancement
with centripetal filling) (14-15) and a poor prognosis (the
presence of a perfusion defect and penetrating vessels) (23). One
promising line of research is the study of the effectiveness of
neoadjuvant chemotherapy using CEUS; Wan et al. have found
that tumor blood perfusion changes occur earlier than tumor
size changes (24).
Although unenhanced or enhanced CDUS data alone cannot
reliably define lesions as malignant or benign, these data can
provide supplementary information to conventional US find-
ings. Consistent with prior work by other researchers (6-12), our
study demonstrated that hypervascular lesions with penetrat-
ing and irregular vessels and a central distribution are related to
malignancy. Thus, we believe that these descriptors could
improve the BI-RADS classification and, therefore, should be
included in the BI-RADS lexicon.
Our study had a noteworthy limitation: namely, the lack
of an objective method of analyzing the kinetic patterns.
Consequently, the true potential of enhanced breast US
cannot be conclusively determined at this time. Despite this
limitation, this study demonstrated the importance of the
vascular analysis of breast masses, which can be easily
performed with unenhanced CDUS.
In conclusion, the present work indicates that the vascular
characteristics observed with spectral and color Doppler US
are associated with the morphological descriptors in the BI-
RADS lexicon, thereby providing new and relevant infor-
mation for determining the nature of breast lesions.
Considering that Doppler functionality is available in
virtually all modern US equipment and that this method
could be implemented easily without adding significant
costs to conventional breast US, we recommend that data
obtained by spectral and color Doppler US be incorporated
into the routine clinical analysis of breast lesions.
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